J. Barratt and J. Feehally, Treatment of IgA nephropathy, Kidney International, vol.69, issue.11, pp.1934-1938, 2006.
DOI : 10.1038/sj.ki.5000419

F. Locatelli, L. Vecchio, and C. Pozzi, IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors, Nature Clinical Practice Nephrology, vol.41, issue.1, pp.24-31, 2006.
DOI : 10.1038/ncpneph0055

L. Villa, P. Boor, and A. Konieczny, Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis, Nephrology Dialysis Transplantation, vol.26, issue.10, pp.3131-3143, 2011.
DOI : 10.1093/ndt/gfr096

S. Krämer, S. Kron, and Y. Wang-rosenke, Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis, AJP: Renal Physiology, vol.294, issue.4, pp.801-811, 2008.
DOI : 10.1152/ajprenal.00148.2007

S. Kondo, M. Shimizu, and M. Urushihara, Addition of the Antioxidant Probucol to Angiotensin II Type I Receptor Antagonist Arrests Progressive Mesangioproliferative Glomerulonephritis in the Rat, Journal of the American Society of Nephrology, vol.17, issue.3, pp.783-794, 2006.
DOI : 10.1681/ASN.2005050519

T. Tanaka, M. Matsumoto, and R. Inagi, Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis, Kidney International, vol.68, issue.6, pp.2714-2725, 2005.
DOI : 10.1111/j.1523-1755.2005.00742.x

T. Nakamura, J. Obata, and H. Kimura, Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis, Kidney International, vol.55, issue.3, pp.877-889, 1999.
DOI : 10.1046/j.1523-1755.1999.055003877.x

M. Tomita, H. Sogabe, and S. Nakazato, Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure, Nephrology Dialysis Transplantation, vol.20, issue.11, pp.2358-2367, 2005.
DOI : 10.1093/ndt/gfi062

T. Shinosaki, I. Miyai, and Y. Nomura, Mechanisms Underlying the Ameliorative Property of Lisinopril in Progressive Mesangioproliferative Nephritis, Nephron, vol.91, issue.4, pp.719-729, 2002.
DOI : 10.1159/000065036

S. Krämer, T. Loof, and S. Martini, Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril, AJP: Renal Physiology, vol.289, issue.2, pp.359-368, 2005.
DOI : 10.1152/ajprenal.00442.2004

M. Asai, T. Monkawa, and T. Marumo, Spironolactone in Combination with Cilazapril Ameliorates Proteinuria and Renal Interstitial Fibrosis in Rats with Anti-Thy-1 Irreversible Nephritis, Hypertension Research, vol.27, issue.12, pp.971-978, 2004.
DOI : 10.1291/hypres.27.971

J. Floege, F. Eitner, and C. Alpers, A New Look at Platelet-Derived Growth Factor in Renal Disease, Journal of the American Society of Nephrology, vol.19, issue.1, pp.12-23, 2008.
DOI : 10.1681/ASN.2007050532

T. Ostendorf, S. Rong, and P. Boor, Antagonism of PDGF-D by Human Antibody CR002 Prevents Renal Scarring in Experimental Glomerulonephritis, Journal of the American Society of Nephrology, vol.17, issue.4, pp.1054-1062, 2006.
DOI : 10.1681/ASN.2005070683

T. Ostendorf, C. Van-roeyen, and J. Peterson, A Fully Human Monoclonal Antibody (CR002) Identifies PDGF-D as a Novel Mediator of Mesangioproliferative Glomerulonephritis, Journal of the American Society of Nephrology, vol.14, issue.9, pp.2237-2247, 2003.
DOI : 10.1097/01.ASN.0000083393.00959.02

T. Ostendorf, U. Kunter, and H. Grone, Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis, J Am Soc Nephrol, vol.12, pp.909-918, 2001.

J. Ibrahim, B. Berk, and A. Hughes, Comparison of Simultaneous Measurements of Blood Pressure by Tail-Cuff and Carotid Arterial Methods in Conscious Spontaneously Hypertensive and Wistar-Kyoto Rats, Clinical and Experimental Hypertension, vol.278, issue.1, pp.57-72, 2006.
DOI : 10.1161/01.RES.0000012460.85923.F0

D. Schiwek, L. Endlich, and . Holzmann, Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines, Kidney International, vol.66, issue.1, pp.91-101, 2004.
DOI : 10.1111/j.1523-1755.2004.00711.x

Y. Liu, Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention, Journal of the American Society of Nephrology, vol.15, issue.1, pp.1-12, 2004.
DOI : 10.1097/01.ASN.0000106015.29070.E7

M. Rastaldi, F. Ferrario, and L. Giardino, Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies, Kidney International, vol.62, issue.1, pp.137-146, 2002.
DOI : 10.1046/j.1523-1755.2002.00430.x

C. Van-roeyen, F. Eitner, and P. Boor, Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D, Kidney International, vol.80, issue.12, pp.1292-1305, 2011.
DOI : 10.1038/ki.2011.278

T. Marshall, R. Lee, and F. Marshall, Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b, Theoretical Biology and Medical Modelling, vol.3, issue.1, pp.1-33, 2006.
DOI : 10.1186/1742-4682-3-1

S. Benson, H. Pershadsingh, and C. Ho, Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPAR??-Modulating Activity, Hypertension, vol.43, issue.5, pp.993-1002, 2004.
DOI : 10.1161/01.HYP.0000123072.34629.57

H. Hsu, S. Hoffmann, and N. Endlich, Mechanisms of angiotensin II signaling on cytoskeleton of podocytes, Journal of Molecular Medicine, vol.18, issue.12, pp.1379-1394, 2008.
DOI : 10.1007/s00109-008-0399-y

J. Wong, C. Rauhoft, and R. Dilley, Angiotensin-Converting Enzyme Inhibition Abolishes Medial Smooth Muscle PDGF-AB Biosynthesis and Attenuates Cell Proliferation in Injured Carotid Arteries : Relationships to Neointima Formation, Circulation, vol.96, issue.5, pp.1631-1640, 1997.
DOI : 10.1161/01.CIR.96.5.1631

V. Kliem, R. Johnson, and C. Alpers, Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats, Kidney International, vol.49, issue.3, pp.666-678, 1996.
DOI : 10.1038/ki.1996.95

S. Taneda, K. Hudkins, and S. Topouzis, Obstructive Uropathy in Mice and Humans: Potential Role for PDGF-D in the Progression of Tubulointerstitial Injury, Journal of the American Society of Nephrology, vol.14, issue.10, pp.2544-2555, 2003.
DOI : 10.1097/01.ASN.0000089828.73014.C8

F. Eitner, E. Bücher, and C. Van-roeyen, PDGF-C Is a Proinflammatory Cytokine that Mediates Renal Interstitial Fibrosis, Journal of the American Society of Nephrology, vol.19, issue.2, pp.281-289, 2008.
DOI : 10.1681/ASN.2007030290

E. Schutyser, S. Struyf, and J. Van-damme, The CC chemokine CCL20 and its receptor CCR6, Cytokine & Growth Factor Reviews, vol.14, issue.5, pp.409-426, 2003.
DOI : 10.1016/S1359-6101(03)00049-2